Cardiovascular disease (CVD): assessment, prediction and policy implications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cardiovascular disease (CVD): assessment, prediction and policy implications ; volume:21 ; number:1 ; day:2 ; month:7 ; year:2021 ; pages:1-14 ; date:12.2021
BMC public health ; 21, Heft 1 (2.7.2021), 1-14, 12.2021
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-021-11334-2
- URN
-
urn:nbn:de:101:1-2021102309261806636295
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rehman, Shazia
- Rehman, Erum
- Ikram, Muhammad
- Jianglin, Zhang
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction to: Cardiovascular disease (CVD): assessment, prediction and policy implications
Major cardiovascular disease (CVD) risk factors in midlife and extreme longevity
Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors
Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank
CVD of nonmetals
Komplexe 06.36 CVD
Senftöpfchen "C.v.d.H"
Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
WHO CVD risk management package for low and medium resource settings : Cardiovascular Disease Programme
Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells
Correction to: Cardiovascular disease (CVD): assessment, prediction and policy implications
Major cardiovascular disease (CVD) risk factors in midlife and extreme longevity
Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors
Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank
CVD of nonmetals
Komplexe 06.36 CVD
Senftöpfchen "C.v.d.H"
Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
WHO CVD risk management package for low and medium resource settings : Cardiovascular Disease Programme
Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells
Correction to: Cardiovascular disease (CVD): assessment, prediction and policy implications
Major cardiovascular disease (CVD) risk factors in midlife and extreme longevity
Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors
Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank
CVD of nonmetals
Komplexe 06.36 CVD
Senftöpfchen "C.v.d.H"
Report from the 3rd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
Report from the 4th Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
Report from the 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group
WHO CVD risk management package for low and medium resource settings : Cardiovascular Disease Programme